We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$377B
| $5.14M | 0.75% |
72,634
+5,133
| +8% | +$366K |
|
27
Wells Fargo
WFC
$261B
| $5.07M | 0.74% |
63,250
-250
| -0.4% | -$18K |
|
28
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $4.91M | 0.72% |
16,161
+865
| +6% | +$243K |
|
29
EOG Resources
EOG
$79.2B
| $4.78M | 0.7% |
39,934
+330
| +0.8% | +$37.7K |
|
30
Zoetis
ZTS
$32.4B
| $4.77M | 0.7% |
30,555
+2,212
| +8% | +$351K |
|
31
Home Depot
HD
$331B
| $4.68M | 0.69% |
12,765
+114
| +0.9% | +$41.3K |
|
32
Waste Management
WM
$90.6B
| $4.58M | 0.67% |
20,007
+140
| +0.7% | +$32.5K |
|
33
MasTec
MTZ
$21.1B
| $4.57M | 0.67% |
26,807
-77
| -0.3% | -$11.1K |
|
34
PepsiCo
PEP
$190B
| $4.57M | 0.67% |
34,573
+126
| +0.4% | +$17K |
|
35
Linde
LIN
$221B
| $4.54M | 0.66% |
9,671
+92
| +1% | +$42K |
|
36
Morgan Stanley
MS
$331B
| $4.48M | 0.66% |
31,825
+476
| +2% | +$58.5K |
|
37
Adobe
ADBE
$99.5B
| $4.47M | 0.65% |
11,552
+107
| +0.9% | +$41.2K |
|
38
Cintas
CTAS
$81.9B
| $4.33M | 0.63% |
19,421
-19
| -0.1% | -$4.09K |
|
39
Church & Dwight Co
CHD
$23.4B
| $4.25M | 0.62% |
44,170
+1,186
| +3% | +$117K |
|
|
FISV
40
Fiserv Inc
FISV
$28.8B
| $4.21M | 0.62% |
24,401
+2,608
| +12% | +$473K |
|
41
Chubb
CB
$135B
| $4.16M | 0.61% |
14,363
+174
| +1% | +$50.1K |
|
|
42
AbbVie
ABBV
$443B
| $4.16M | 0.61% |
22,413
+21,388
| +2,087% | +$3.97M |
|
43
O'Reilly Automotive
ORLY
$72.9B
| $4.15M | 0.61% |
46,042
+1,207
| +3% | +$110K |
|
44
Verizon
VZ
$195B
| $4.13M | 0.61% |
95,511
+2,329
| +2% | +$101K |
|
45
CME Group
CME
$96.3B
| $4.05M | 0.59% |
14,677
+14
| +0.1% | +$3.81K |
|
46
Broadridge
BR
$17.8B
| $4.03M | 0.59% |
16,571
+553
| +3% | +$131K |
|
47
TJX Companies
TJX
$174B
| $4M | 0.59% |
32,406
+1,421
| +5% | +$180K |
|
48
Microchip Technology
MCHP
$40.3B
| $3.97M | 0.58% |
56,355
+9,361
| +20% | +$515K |
|
49
Brown & Brown
BRO
$23.6B
| $3.91M | 0.57% |
35,241
-21
| -0.1% | -$2.36K |
|
50
Tesla
TSLA
$1.23T
| $3.88M | 0.57% |
12,213
+482
| +4% | +$145K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.